The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer
- PMID: 22699202
- DOI: 10.1097/MPA.0b013e318252f4f5
The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer
Abstract
Objectives: Routine application of positron emission tomography/computed tomography (PET/CT) for pancreatic cancer staging remains a controversial approach. The purpose of this study was to reassess the clinical impact of PET/CT for the detection of distant metastasis of pancreatic cancer.
Methods: From January 2006 to June 2009, 125 patients with histologically proven pancreatic cancer that had undergone PET/CT at our hospital were retrospectively reviewed. To evaluate the clinical efficacy of PET/CT on the management plan, the post-PET/CT management plans were compared with the pre-PET/CT management plans.
Results: After the conventional staging workup, we determined that 76 patients (60.8%) had resectable lesions, whereas 48 patients had unresectable lesions. One patient underwent explorative laparotomy due to equivocal resectability. Positron emission tomography/computed tomography diagnosed distant metastasis in only 2 (2.6%) of the 76 patients with resectable lesions, and these patients did not undergo unnecessary surgical treatment. Complete resection was not performed in 8 of the 74 operative patients because they had distant metastasis detected during the operative procedure. Positron emission tomography/computed tomography diagnosed distant metastasis in 32 of the 44 patients with metastatic lesions that were histologically shown to have sensitivity of 72.7%.
Conclusions: Positron emission tomography/computed tomography has a limited role in the evaluation of metastatic disease from pancreatic cancer.
Similar articles
-
Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.Pancreas. 2013 Jan;42(1):11-9. doi: 10.1097/MPA.0b013e3182550d77. Pancreas. 2013. PMID: 22699206
-
The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma.Hepatogastroenterology. 2014 Oct;61(135):2102-9. Hepatogastroenterology. 2014. PMID: 25722999
-
Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.ANZ J Surg. 2012 Mar;82(3):140-4. doi: 10.1111/j.1445-2197.2011.05972.x. Epub 2012 Jan 17. ANZ J Surg. 2012. PMID: 22510123
-
The role of positron emission tomography in the management of pancreatic cancer.Semin Nucl Med. 2006 Jul;36(3):248-56. doi: 10.1053/j.semnuclmed.2006.03.005. Semin Nucl Med. 2006. PMID: 16762614 Review.
-
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.Ann Surg. 1999 May;229(5):729-37; discussion 737-8. doi: 10.1097/00000658-199905000-00016. Ann Surg. 1999. PMID: 10235532 Free PMC article. Review.
Cited by
-
Metastatic pancreatic cancer: Mechanisms and detection (Review).Oncol Rep. 2021 Nov;46(5):231. doi: 10.3892/or.2021.8182. Epub 2021 Sep 9. Oncol Rep. 2021. PMID: 34498718 Free PMC article. Review.
-
The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patients.HPB (Oxford). 2016 Jan;18(1):57-64. doi: 10.1016/j.hpb.2015.06.001. Epub 2015 Dec 21. HPB (Oxford). 2016. PMID: 26776852 Free PMC article.
-
Impact of F-18 Fluorodeoxyglucose PET/CT and PET/MRI on Initial Staging and Changes in Management of Pancreatic Ductal Adenocarcinoma: A Systemic Review and Meta-Analysis.Diagnostics (Basel). 2020 Nov 14;10(11):952. doi: 10.3390/diagnostics10110952. Diagnostics (Basel). 2020. PMID: 33202682 Free PMC article. Review.
-
Investigation of Association Between Borderline Pancreatic Head Cancer and Glucose Uptake by Using Positron-Emission Tomographic Studies.Med Sci Monit. 2017 Oct 16;23:4947-4953. doi: 10.12659/msm.904746. Med Sci Monit. 2017. PMID: 29036034 Free PMC article.
-
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.Cochrane Database Syst Rev. 2016 Sep 15;9(9):CD011515. doi: 10.1002/14651858.CD011515.pub2. Cochrane Database Syst Rev. 2016. PMID: 27631326 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical